Vetr Upgrades Celgene After Drug Trial Stalls
October 23, 2017 at 17:06 PM EDT
The Vetr crowd on Monday upgraded its rating on Celgene Corporation (NASDAQ: CELG) from 3 stars (Buy) issued 16 days ago, to 5 stars ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.